Search Orphan Drug Designations and Approvals
-
Generic Name: | Cisplatin transmucosal system |
---|---|
Date Designated: | 07/13/2022 |
Orphan Designation: | Treatment of carcinoma in situ (CIS) of the anterior 2/3 of the oral cavity |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Privo Technologies 200 Corporate Place Suite 6b Peabody, Massachusetts 01960 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-